SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-048756
Filing Date
2008-07-31
Accepted
2008-07-31 07:00:49
Documents
10
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-18628_110q.htm 10-Q 1222592
2 EX-10.1 a08-18628_1ex10d1.htm EX-10.1 68951
3 EX-10.2 a08-18628_1ex10d2.htm EX-10.2 8737
4 EX-10.3 a08-18628_1ex10d3.htm EX-10.3 10550
5 EX-10.4 a08-18628_1ex10d4.htm EX-10.4 6851
6 EX-12.1 a08-18628_1ex12d1.htm EX-12.1 37577
7 EX-31.1 a08-18628_1ex31d1.htm EX-31.1 14572
8 EX-31.2 a08-18628_1ex31d2.htm EX-31.2 12934
9 EX-32.1 a08-18628_1ex32d1.htm EX-32.1 7628
10 EX-32.2 a08-18628_1ex32d2.htm EX-32.2 7605
  Complete submission text file 0001104659-08-048756.txt   1399381
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 08980386
SIC: 2834 Pharmaceutical Preparations